Table 1.
Patient demographics and tumor characteristics (n = 50).
| PCA (n = 25) | TEA (n = 25) | P-value | |
|---|---|---|---|
| Age (y) [median (minimum – maximum)] | 70 (48–85) | 63 (48–80) | .14 |
| Gender [n (%)] | >.99 | ||
| Male | 22 (88) | 22 (88) | |
| Female | 3 (3) | 3 (3) | |
| BMI (kg/m2) [median (minimum – maximum)] | 25 (15–46) | 25 (18–32) | .99 |
| Comorbidity [n (%)] | |||
| No comorbidity | 7 (28) | 10 (40) | .37 |
| Vascular | 8 (32) | 11 (44) | .38 |
| Cardiac | 5 (20) | 2 (8) | .22 |
| Diabetes | 5 (20) | 5 (20) | >99 |
| Pulmonary | 6 (24) | 3 (12) | .27 |
| Oncologic | 2 (8) | 3 (12) | .64 |
| Previous abdominal operation | 7 (28) | 6 (24) | .75 |
| Neurologic | 0 (0) | 2 (8) | .15 |
| ASA score [n (%)] | .34 | ||
| 2 | 13 (52) | 13 (52) | |
| 3 | 12 (48) | 12 (48) | |
| Tumor location [n (%)] | .93 | ||
| Middle esophageal | 4 (16) | 4 (16) | |
| Distal esophageal | 17 (68) | 16 (64) | |
| GEJ | 4 (16) | 5 (20) | |
| Tumor type [n (%)] | .22 | ||
| Adenocarcinoma | 19 (76) | 20 (80) | |
| Squamous cell carcinoma | 6 (24) | 5 (20) | |
| Operation type [n (%)] | .73 | ||
| Ivor-Lewis | 25 (100) | 24 (96) | |
| McKeown | 0 (0) | 1 (4) | |
| Neoadjuvant treatment [n (%)] | .11 | ||
| No therapy | 6 (24) | 1 (4) | |
| Chemotherapy | 7 (28) | 11 (44) | |
| Chemoradiotherapy | 12 (48) | 13 (52) | |
Table 1: PCA = patient-controlled analgesia, BMI = body mass index, ASA = American Society of Anesthesiologists, TEA = thoracic epidural analgesia.